Safety and Efficacy of Using CBUS™ System for Ultrasound Breast Imaging Designed for Breast Tumor Diagnosis

NCT00355745 | Terminated

• 1 other identifier: CBUS -RA-001
• Study Type: interventional
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

In the United States, breast cancer is the most common cancer occurring in women (excluding cancers of the skin) and the second most common cause of death from cancer in women (after lung cancer). Approximately 182,800 new cases per year occur in the United States, causing 40,800 death cases per year. Breast cancer is the leading cause of death in women aged 44-50 years. The 5-year survival rate is 60% overall but is greater than 80% for early disease. If diagnosed at an early stage, breast cancer has an encouraging cure rate: up to 97% of women diagnosed with localized breast cancer will survive five years after their diagnosis. Even if the cancer is found at a more advanced stage, new therapies have enabled many people with breast cancer to experience the same quality of life as before their diagnosis. Breast ultrasound (US) is an extremely useful modality in the diagnosis of breast disease in the symptomatic clinic. It is routinely used as an adjunct to x-ray mammography and clinical examination and, with younger patients it may be the sole imaging modality. It has well-established value in differentiating between malignant and benign solid lesions in some cases, however, it cannot replace fine needle aspiration and core biopsy. Conventional breast US scanning is highly operator- dependent, requiring skillful probe manipulation and the mental ability to envisage 3-D tissue structure. Acquiring 3-D US data sets may be advantageous, making it easier to see and interpret 3-D structures, boundaries and interactions. CBUS™, Circular Breast Ultrasound Scanner is indicated to improve significantly breast images obtained by ultrasound systems. The CBUS™ system automatically acquires a complete breast image and constructs a high quality 3D image of the scanned breast. These images provide diagnostic information of the complete volume of breast tissue including blood flow in a single ultrasonic 3D image. In this clinical study, the CBUS™ Circular Breast Ultrasound Scanner will be used to automatically image the complete breast and provides a high quality 3D image of the scanned breast.

Conditions

Breast Cancer

Keywords

Breast; tumor; ultrasound; biopsy; Breast mammographic or ultrasound findings

Outcome Measures

Primary Outcomes (1)

• Occurrences of adverse events

  immediately

Secondary Outcomes (1)

• Quality of ultrasound imaging

  within 1 day

Interventions

Ultrasound breast scanning DEVICE

breast scanning

Eligibility Criteria

• Age: 21 Years - 70 Years
• Sex: female
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Female age between 21-70 years.
• Subject has mammography or ultrasound findings
• Subject is scheduled for biopsy.
• Subject is scheduled for ultrasound breast scan.
• Subject understands the study procedure.
• Subject is willing to sign the inform consent and comply with the study requirements.

You may not qualify if:

• Age \< 21 years or \> 70 years.
• Subject undergo previous breast surgery
• Known blood coagulation disorders.
• Known cardiac disorders.
• Breast infection / breast abscess / breast pains.
• Ipsilateral breast scar in same quadrant as current lesion
• Recent breast trauma.
• Pregnant or lactating woman
• Subject has bleeding disorder.
• Subject is suffering extreme general weakness.
• Subject objects to the study protocol.
• Physician objection.
• Known cognitive or psychiatric disorder
• Participation in any other clinical trial

Sponsors & Collaborators

• Helix Medical Systems: lead

Study Sites (1)

RAMBAM Medical Center

Haifa, Israel

Location

MeSH Terms

Conditions

Breast Neoplasms; Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by Site; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases

Study Officials

• Hanna Levy, PhD

  Rambam Health Care Campus

  STUDY DIRECTOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: NONE
• Purpose: DIAGNOSTIC
• Intervention Model: SINGLE GROUP
• Sponsor Type: INDUSTRY

Study Record Dates

• First Submitted: July 22, 2006
• First Posted: July 25, 2006
• Study Start: July 1, 2006
• Primary Completion: December 1, 2008
• Study Completion: July 1, 2009
• Last Updated: June 9, 2011

Record last verified: 2008-05

Locations

IL (1)